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Abstract 
Objective: To evaluate the responsiveness of generic and mapped preference-based measures 
based on the anchor of global change in health condition of colorectal cancer (CRC) patients.  
Study Design and Setting: A baseline sample of 333 Chinese CRC patients was recruited 
between 09/2009 and 07/2010, and was surveyed prospectively at 6-month follow-up. 
Preference-based indices were derived from the generic SF-6D measure (SF-6DDirect), from 
the Short Form-12 (SF-6DSF-12) and mapped from the condition-specific Functional 
Assessment of Cancer Therapy-Colorectal (SF-6DFACT-C). Responsiveness of three measures 
was assessed using standardized effect size, standardized response mean, and responsiveness 
statistic, and receiver operating characteristic (ROC) curve analysis. 
Results:  The SF-6DSF-12 and SF-6DFACT-C indices were significantly more responsive to 
detect positive changes than the SF-6DDirect index in improved groups. In worsened group, the 
SF-6DDirect and SF-6DFACT-C indices showed significant decline from baseline to 6-month. 
The areas under the ROC curve for SF-6DDirect and SF-6DFACT-C indices were not statistically 
different from 0.7. The SF-6DFACT-C index was more responsive to changes in health status 
compared with other indices. 
Conclusion: Direct SF-6D measure was more responsive than mapped preference-based 
measures in improved group but the direction was reversed in worsened group. Use of a 
preference-based index mapped from a condition-specific measure captures both negative and 
positive important changes among CRC.  
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What is new? 
 
Key finding: 
- The preference-based measure mapped from condition-specific FACT-C was 
responsive in both improved and worsened groups for patients with colorectal cancer. 
- Direct preference-based measure was more responsive than mapped preference-based 
measures in improved group but the direction was reversed in worsened group. 
What this adds to what was known: 
- Responsiveness of generic and mapped preference-based measures was compared in a 
cancer population for the first time. 
What is the implication, what should change now: 
- Use of algorithm that maps condition-specific measure onto preference-based 
measure improved the responsiveness in patients with colorectal cancer. 
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Manuscript Text 
Introduction 
 
Colorectal cancer (CRC) is highly prevalent around the world [1], and the costs of 
treatment for CRC for health services are projected to increase [2]. Continuing advances in 
pharmaceutical and other treatments for CRC has meant that research has been directed 
towards developing and testing interventions with evidence of both clinical and cost 
effectiveness. In economic evaluations, the quality adjusted life year (QALY), that combines 
the quantity and quality of life into a single metric, can be used as the outcome measure [3]. 
The quality weight can be gained from a preference-based measure, which provides a single 
figure utility score (anchored on the 1 to 0; full health – dead scale) that is derived from the 
preferences of the general population for certain health states described by the measures over 
others.  A range of generic preference-based measures are available (including the EQ-5D, 
SF-6D and HUI-3), and it is also possible to map condition specific measures onto the utility 
scale[4].  In part, the choice of measure to use can be informed by the psychometric 
properties of the instrument, including responsiveness, a subcategory of validity[5]. 
Responsiveness refers to the ability of a measure to detect the clinically important changes in 
health over time[6].  It is an important measurement property for preference-based indices 
because health policy implications and reimbursement decisions are impacted by the level at 
which preference-based indices capture actual changes in health linked to an intervention. 
 
Country specific scoring algorithms to produce preference-based indices are available. 
In China, there is currently no EQ-5D value set but an SF-6D preference-based index is 
available and has been validated[7]. The responsiveness of the SF-6D alongside other generic 
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preference-based measures has been examined in patients with cataract and heart failure[8], 
stroke[9], psychosomatic disorder[10, 11], rheumatic diseases[12-16], spine problems[17], 
knee pain[18], and HIV [19]. Two longitudinal studies have compared the responsiveness of 
HRQOL instruments in patients with CRC[20, 21]. Condition-specific HRQOL instruments 
were found to be more responsive than generic instruments except for the domains linked to 
social functioning[20]. However, neither study tested the responsiveness of preference-based 
measures in CRC.  
 
Related to this patient group, preference-based indices can be estimated by three 
approaches: 1) direct elicitation techniques for CRC health states using time-trade off or/and 
standard gamble[22-26]; 2) indirect elicitation though the use of  preference-weighted scoring 
valued by health state classification system such as SF-6D[27, 28] and EQ-5D[29-33]; and 3) 
indirect elicitation though the use of mapping algorithms that map condition-specific 
measures (EORTC[34] and FACT-C[35]) onto the preference-based utility scale using 
regression. This means that preference-based indices can be derived in trials and studies 
where a generic measure such as EQ-5D or SF-6D has not been used. The responsiveness of 
SF-6D preference-based index derived from SF-36 and SF-12 appeared similar across seven 
patient groups[36], providing evidence on the psychometric property of the SF-6D index 
derived from SF-12 in Western populations. There is limited work comparing the 
psychometric properties of the indices generated using the different methods. Thus, the 
responsiveness of the SF-6D index has not been tested in a Chinese population with CRC. 
 
The aims of this study were to examine the internal and external responsiveness of 
three preference-based SF-6D indices: 1. Derived from asking respondents the directly 
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complete the SF-6D questionnaire; 2. Derived from the SF-12v2; and 3. Mapped from the 
FACT-C to the SF-6D based on a self-reported health change anchor. This enabled us to 
compare the responsiveness of the indices among groups of patients who self-reported both 
increases and decreases in health status, and those whose health did not change. 
 
Methods 
 
Subject and Study Design 
 
A total of 698 patients attending colorectal specialist outpatient clinics of an academic 
teaching hospital in Hong Kong, China were contacted from September 2009 to July 2010. 
The inclusion criteria were aged 18 years or above with a documented diagnosis of colorectal 
polyp or cancer for at least 6 months. The exclusion criteria were: 1) their life expectancy to 
be less than 6 months, 2) unable to communicate in Chinese/Cantonese, 3) too ill to carry out 
an interview, and 4) refused to give consent. Of relevance to the current study, patients with 
colorectal polyp were excluded. The remaining 386 (55.3%) patients participated in the 
baseline visit by completing a set of questionnaires including the SF-6D and FACT-C 
(condition-specific) HRQOL instruments. At 6-month follow-up, 333 (86.3%) subjects also 
completed the questionnaires by telephone. The interviewers were instructed to go through 
each item stating from the beginning to the end of the questionnaire and to standardize how 
each item and its response options should be read out during the interviews at baseline and 6-
month follow-up. Subject recruitment and data collection procedures were described in detail 
Running Title: Responsiveness of SF-6D measures for CRC 
JCE Manuscript 20130807 clean.docx  Page 7 of 22 
elsewhere[20]. The protocol was approved by the local Ethics Committee (IRB Ref# UW 09-
391) and the trial was registered with HK Clinical Trial Register (#HKCTR-973). 
 
 
Health Anchor 
 
All subjects also answered an one item Global Rating on Change Scale (GRS) to 
evaluate their subjective changes in global health condition by a retrospective question 
“Compared to the first visit (six months ago), how would you rate your overall health 
now?”[37]. The response was rated on a 7-point ordinal scale ranging from -3 to 3 anchored 
from the much worse to the much better options, with 0 indicating no change. GRS anchors 
have been commonly used as the external criterion of change on the estimation of minimally 
clinically importance difference of HRQOL measures[38-40], and applied in longitudinal 
studies comparing the responsiveness of HRQOL measures in colorectal cancer[20, 21] and 
responsiveness of preference-based measures[10, 16, 19, 41]. 
 
HRQOL Instruments 
 
The Chinese (HK) Short Form-6 Dimensions (SF-6D) 
 
The SF-6D is a generic preference-based measure for the generation of a composite 
index value on a scale of 0 (death) to 1 (full health). It consists of six dimensions namely 
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physical functioning (PF), role limitation (RL), social functioning (SF), bodily pain (BP), 
mental health (MH) and vitality (VT). The SF-6D scoring algorithm has been validated and 
established to produce direct SF-6D preference-based index, denoted as SF-6DDirect, for the 
adult Chinese population in Hong Kong[42].  
 
The Chinese (Hong Kong) Short Form-12 version 2 (SF-12v2) 
 
The SF-12v2 Health Survey is a generic HRQOL measure with eight subscales 
(Physical functioning, PF; Role physical, RP; Bodily pain, BP; General health, GH; Vitality, 
VT; Social functioning, SF; Role emotional, RE; Mental health, MH), ranging from 0 to 
100[36]. This generic instrument is shown to be valid and reliable in Chinese population [43, 
44]. Seven out of twelve items from SF-12v2 has been selected to derive the SF-6D 
preference-based index, denoted as SF-6DSF-12, based on a preference-weighted scoring 
algorithm [42]. 
 
The Functional Assessment of Cancer Therapy-Colorectal (FACT-C) 
 
The Functional Assessment of Cancer Therapy-Colorectal (FACT-C) is an extension 
of the FACT-G HRQOL instrument that emphasizes on a range of important aspects of 
quality of life specific to patients with CRC [45]. This condition-specific HRQOL instrument 
has been shown to have acceptable validity in Chinese patients with colorectal neoplasm 
using classical[46] and modern psychometric methods[47]. Four (Physical, emotional, 
functional well-being and colorectal cancer subscale) out of five subscales from FACT-C 
have been used to derive mapped SF-6D preference-based indices, denoted as SF-6DFACT-C 
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[35]. Based on pilot data assessing the reproducibility [46], the intra-class correlation 
between in-person and telephone administration ranged from 0.66 to 0.82 for each subscale 
of FACT-C, resulting in acceptable reproducibility. 
 
Statistical Analysis 
 
The SF-6D preference-based measures (SF-6DDirect, SF-6DSF-12 and SF-6DFACT-C) were 
derived from either preference-weighted scoring for the SF-6D or a mapping algorithm based 
on the source of SF-12v2[42] and  FACT-C[35] instrument. The descriptive statistics (mean 
± standard deviation and median) in SF-6DDirect, SF-6DSF-12 and SF-6DFACT-C were calculated. 
The ceiling and floor effects were compared and considered to be present if over 15% of 
subjects reported the minimum or maximum possible score [48]. The presence of a large 
ceiling effect may impact on responsiveness as the measure will not be able to detect an 
increase in health for patients reporting the highest possible score.  The presence of a floor 
effect means that the measure may not be sensitive to decreases in health status amongst 
those reporting the lowest possible score. 
Responsiveness was assessed using the self-reported health change anchor to define 
samples reflecting no change (rating of 0), improvement (rating of 1 to 3) and deterioration 
(rating of -3 to -1) in health status [49]. Mean and standard deviation of all HRQOL scores 
were calculated for each sample. 
 
According to a literature review study [50], the assessment of responsiveness was 
characterized by two major aspects: “internal responsiveness” and “external responsiveness”.  
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For assessing the internal responsiveness, mean changes in HRQOL score over the past six 
months in patients with “Deterioration”, “Unchanged” and “Improvement” were tested by 
paired t-test. Mean changes in utility were regarded as clinically important differences when 
the changes exceeded the absolute magnitude of 0.04, which was the mean minimally 
important difference of SF-6D[51]. The HRQOL score differences between baseline and 
follow-up assessments were also tested using the standardized effect size (SES)[37], 
standardized response mean (SRM)[52] and responsiveness statistics (RS)[6, 41, 53] 
separately for patients in each group. Three responsiveness statistics were reported because 
the method for calculating the most appropriate responsiveness statistic was still controversial 
[50]. The SES, SRM and RS were determined by dividing the observed differences between 
baseline and follow-up scores by the standard deviation of all subjects at baseline, the 
standard deviation of observed differences, and the standard deviation of observed 
differences among “Unchanged” group, respectively. The formula of these statistics is 
reported in the following: 
 
Standardized Effect Size (SES) = (µFollowup- µBaseline)/σBaseline 
Standardized Response Mean (SRM) = (µFollowup- µBaseline)/σFollowup-Baseline 
Responsiveness statistic (RS) = (µFollowup- µBaseline)/ σ(Followup-Baseline)Unchanged 
 
The value of SES, SRM and RS were interpreted as trivial for <0.2, small for ≥0.2 and 
<0.5, moderate for ≥0.5 and <0.8 or large for ≥0.8, according to criteria defined by Cohen 
[54], Liang [52] and Norman [55] respectively. Internal responsiveness was supported if 
these changes are interpreted as small or above. 95% bootstrap bias-corrected and accelerated 
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confidence intervals [56] for SES, SRM and RS were obtained using the bootstrapping 
estimation method with 2000 replications. 
 
For assessing the external responsiveness, the  “Worsened” group was compared with 
“Unchanged” and “Improved” groups. Independent t-tests were performed to compare the 
HRQOL score in patients among two groups. External responsiveness was determined by not 
only the score change between groups but also ROC curve analysis [50] that assesses the 
ability of the instrument to detect HRQOL score change with health condition changes, or to 
discriminate between groups. The ROC curve is a plot of the true-positive rate (sensitivity) 
against the false-positive rate (1-specificity). Conceptually, the area under ROC curves (AUC) 
represents the probability of a random patient with unchanged/improved health status to have 
a higher HRQOL score than a random patient with worsened health status. Perfect 
discriminatory power is defined as a value of 1 but a value of 0.5 is considered no 
discriminatory power. The adequate threshold of AUC was considered as 0.7 [48] and its 
95% confidence intervals were reported to assess if the confidence interval contained the 
adequate threshold of 0.7. Moreover, the Pearson correlation between GRS and score change 
from baseline to follow-up was presented to assess the external responsiveness. The 
correlation was considered small for the coefficient between 0.1 and 0.3, moderate for the 
coefficient between 0.3 and 0.5 and large for coefficient larger than 0.5 [54]. External 
responsiveness was supported if the 95% confidence interval of AUC contained the adequate 
threshold of 0.7 and the Pearson correlation was statistically significant. 
 
The preference-based indices tested were regarded as more responsive overall when it 
was found to be both internally and externally responsive. All statistical analyses were 
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conducted by the SPSS version 20.0 for Windows (SPSS, IBM Inc., Chicago, Illinois, USA). 
P-value < 0.05 was considered as statistically significant. 
 
Results 
Baseline Characteristics 
 
The baseline characteristics of all respondents and those who did and did not 
complete follow up are shown in Table 1. The majority of patients were male, married, not 
currently working, low income, non-smoker and non-drinker at baseline. There was no 
significant difference in the characteristics of those who did and did not complete follow up, 
except in the proportion of people on active treatment and distribution of cancer stage. 
Subjects with advanced cancer stage or palliative treatment were more likely to default than 
subjects without. 
 
Baseline and 6-month follow-up on the HRQOL scores are shown in Table 2. In 
baseline and 6-month follow-up, the score of SF-6DDirect, SF-6DSF-12 and SF-6DFACT-C were 
greater than 0.8. SF-6DDirect and SF-6DSF-12 detected statistically significant mean changes 
between the two time points. There were no floor and ceiling effects for the SF-6DDirect and 
SF-6DFACT-C at either baseline or 6-month follow-up. Table 3 shows that most subjects 
reported no change (52.0%) in global health, and 15.1% and 32.9% of patients rated better 
and worse health conditions respectively. 
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Internal Responsiveness 
 
A summary of mean change and responsiveness statistics in each health state change 
group (i.e. worsened, unchanged and improved) is shown in Table 4 and is illustrated in 
Figure 1.  For the group where health worsened, the mean of SF-6DDirect and SF-6DFACT-C 
between baseline and 6 months follow-up was significantly different and also exceeded the 
minimum clinically important changes of 0.04. SF-6DDirect and SF-6DFACT-C had moderate 
sensitivity to change in SES, SRM and RS and illustrated a greater sensitivity to change than 
SF-6DSF-12. For the unchanged group, there was no significant difference in the mean change 
of SF-6DDirect, SF-6DSF-12 and SF-6DFACT-C as expected.  For the improved group, significant 
differences were found in the mean of SF-6DSF-12 and SF-6DFACT-C between baseline and 
follow up but the mean changes in SF-6DDirect and SF-6DFACT-C did not exceed the clinically 
important changes of 0.04. Despite the small changes with SES, SRM and RS in the SF-6DSF-
12 and SF-6DFACT-C, these were more sensitive to change than SF-6DDirect.   
 
As far as internal responsiveness was concerned, SF-6DDirect had the best sensitivity to 
change in the health decrease group, but did not perform as well in the health improvement 
group. SF-6DSF-12 performed well in the health improvement group but unsatisfactorily in the 
health decrease group. In comparison, SF-6DFACT-C had satisfactory performance in all three 
groups - deteriorated, unchanged and improved groups. 
 
External responsiveness 
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Table 5 and Figure 2 show the similar result of mean change and AUC of the ROC 
between “Worsened” and “unchanged” group as well as that between “Worsened” and 
“improved” group. Mean differences for SF-6DDirect and SF-6DFACT-C were statistically 
significant. The correlation coefficients for SF-6DDirect, SF-6DSF-12 and SF-6DFACT-C were 
small. However, the 95% confidence interval of AUC for SF-6DDirect and SF-6DFACT-C 
overlapped with the adequate threshold of 0.70 so they could be able to distinguish between 
patients who had worsened from those who had not.  
 
Discussion 
 
For Chinese patients with CRC, there are a number of methods for estimating SF-6D 
preference-based indices, including directly administering by the SF-6D instrument[42], 
derived from the generic SF-12v2 instrument[42], and mapping from the FACT-C[35] 
instrument This study has found evidence of differences in the level of responsiveness of 
preference-based indices derived using these different methods. This is the first study, to our 
knowledge, assessing the comparative responsiveness of preference-based indices using 
direct and mapped SF-6D preference-based measures in cancer populations using indicators 
of both “internal” and “external” [50] responsiveness that have been utilized in previous 
studies[12, 20].  
 
Mapping functions are principally designed to provide preference-based indices for 
economic evaluation when a generic measure has not been used, and is characterized as an 
alternative and second-best way of obtaining utility values[4]. It is unclear whether mapped 
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SF-6D scores are as responsive as generic SF-6D scores. In those whose health was 
unchanged, the measures did not show change over time. This is as expected, and provides 
evidence of the reliability of the instruments. 
 
In the group where health got worse, the direct preference-based index was more 
responsive to change on the basis of three responsiveness statistics than preference-based 
measures derived from SF-12v2 and FACT-C instruments. Between indices derived from SF-
6D and SF-12, possible explanation of the worsened subjects favoring direct preference-
based measure were the discrepancy between descriptive systems and tariff set for the 
convention of directly administered SF-6D and SF-12v2 data. Direct measure required the 
complete responses of six items whereas the seven out of twelve items in SF-12 were 
administered to produce the index. According to the scoring algorithm converting raw SF-6D 
responses to SF-6D preference-based index, several health states have been shown to result in 
a significantly larger decrement. In cases of the worse possible health states in physical 
functioning and bodily pain was the strong reflection of reasonably lower valuations of SF-
6D scores in worsened group, while direct preference-based index enabled to capture the 
more severe levels of quality of life compared to preference-based measures from SF-12. In 
contrary, the direct preference-based measure was not responsive to change in improved 
group whereas the mapped preference-based measures were significantly responsive to 
change in improved group. It might be due to the greater relevance of the FACIT instrument 
to the health condition, leading to the increasingly responsive to change over time. However 
mapping functions are not without concerns, including the inherent level of error between the 
actual and predicted utility values [57]. It was expected that mapping algorithm may lead to 
the slight over-estimation of preference-based measure when the subjects rated at less severe 
end of preference-based index. As a whole, mapped preference-based indices sufficiently 
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captured improvement and deterioration in patients with CRC which provides some support 
for the use of mapped utility values in colorectal neoplasm patients.   
 
Studies comparing the responsiveness of the SF-6D and EQ-5D[11, 13, 14, 16, 18, 19] 
have concluded that the SF-6D was more responsive than the EQ-5D in the health 
improvement group but the opposite phenomenon was apparent in the sample whose health 
worsened. Few studies [12-14] reported that relatively small variance in SF-6D derived from 
SF-36 provided a conservative estimation in QALYs for the cost-effectiveness analysis of 
interventions. , Since the direct preference-based index was responsive to change for those 
whose health deteriorated from healthy to severe health states, the preference-based indices 
tended to result in a higher QALY gained and lower cost per QALYs gained calculated with 
preference-based indices administered directly by SF-6D compared with scores derived from 
other generic or condition-specific instruments. Appraised interventions adopting the direct 
preference-based index may have a higher likelihood of being cost-effective strategy  in 
theoretical sense. Conversely, appraised interventions undertaken in patients following 
pathway of disease trajectories starting from treatment to pro-treatment recovery deemed to 
vary in both positive and negative direction with considerable magnitude.  
 
The limitations of current study should be noted. First, a general self-reported 
retrospective health anchor was used but it is debatable whether this is the most appropriate 
anchor.  This is because the anchor may not strongly relate to change across the other generic 
and condition specific measures, and also due to potential recall bias [49]. Taking this into 
consideration, several previous studies [9, 10] collected multiple independent anchors in 
terms of clinical endpoint-based, patient-based or physician-based anchors. Further studies 
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exploring different aspects of anchors can be warranted. Second, there was a high frequency 
of patients in one category of the anchor with over half of subjects (52.0%) self-reporting 
“unchanged” health over time.. Thirdly, patients with colorectal polyp were excluded from 
this analysis although polyp patients were also recruited in our sampling plan. The focus on 
colorectal cancer only was due to the fact that colorectal cancer and polyp patients differed 
with respect to their treatment, the severity of disease, and level of HRQOL. Fourth, the 
differences in administration modes between the two time assessments may contribute to 
potential differences in HRQOL scores and impact on responsiveness. According to a 
randomized study on administration modes[58], cancer patients were found to inflate their 
HRQOL and report more socially favorable desirable responses when the HRQOL instrument 
was interviewer-administered. Given that the baseline and follow-up assessments were 
interviewer-administered, both the in-person and telephone administrations may be subject to 
social desirability bias. Finally, patients were recruited at a single clinical site (Queen Mary 
Hospital) rather than across multiple centers, and this limits the generalizability of the results 
to the wider Chinese population. 
 
Conclusion 
 
 The direct SF-6D measure was more responsive than mapped preference-based 
measures in worsened group but the direct SF-6D was not responsive in improved group. The 
mapped SF-6D had satisfactory performance in all three health change groups. The use of a 
preference-based index mapped from a condition-specific measure captures both negative and 
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positive change in HRQOL among CRC patients. Furthermore, the external responsiveness 
from the mapped SF-6D measure was greater compared with the direct SF-6D measure. 
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